Mesenchymal stem cells ... that drive hepatic fibrosis. These immunomodulatory, antifibrotic, and liver specific features make HepaStem cells well-suited to the treatment of hepatic diseases ...
HepaStem is a highly advanced cell therapy platform consisting of human liver-derived stem cells that are ethically ... thereby reducing fibrosis (Fig. 1). This combination of immunomodulatory ...
The ECM components in fibrotic liver are similar regardless of the underlying cause. Activation of hepatic stellate cells is the ... of diagnosis and treatment of hepatic fibrosis.
which causes fibrosis of the liver. This buildup of collagen and other fibrous tissue accelerates when hepatic stellate cells become activated during hepatitis, often resulting in liver cancer or ...